Target intelligence / Profile preview

Polymerase basic protein 2 subunit of influenza A virus (PB2)

Target
PB2
Molecular classification
Enzyme, RNA-dependent RNA polymerase subunit, Viral protein
01

Overview

Polymerase basic protein 2 (PB2) is a key subunit of the influenza A virus heterotrimeric RNA-dependent RNA polymerase complex, which consists of PB2, PB1, and PA. PB2 is primarily responsible for recognizing and binding the 5′ cap of host pre-mRNA transcripts, a prerequisite step for "cap-snatching"—where short host-capped RNA fragments are used to prime viral mRNA synthesis. PB2 is also involved in the interface with PB1, regulating overall polymerase activity and complex formation essential for virus replication. Mutations in PB2, particularly within its 627 domain and its mitochondrial targeting sequence, are critical for host adaptation, influencing both the efficiency of viral replication and pathogenicity in humans versus avian hosts. PB2's unique structural conservation and central catalytic functions have made it a prime target for antiviral drug development. Besides its canonical nuclear function, mitochondrial localization of PB2 has been implicated in the regulation of cell death and dampening of innate immune responses, providing additional routes by which influenza A manipulates host defenses.

Other names
PB2Polymerase basic protein 2Influenza A virus PB2
02

Mechanism of action

Inhibition of cap-binding or polymerase activity Interference with PB1–PB2 interaction Inhibition of RNA synthesis

03

Biological functions

Viral RNA transcriptionViral RNA replicationCap-snatching (primer generation for viral mRNA)Regulation of apoptosis and innate immune response (via mitochondrial import and MAVS inhibition)
04

Disease associations

Infection (specifically influenza A)Pathogenicity determinationHost adaptation
05

Safety considerations

Potential for rapid resistance development if targeted directlyCross-species variability affecting drug efficacy and resistance
06

Interacting drugs

Baloxavir marboxil (targets the polymerase complex; direct PB2 inhibitors in research)

1 more in the full profile.

07

Biomarkers

PB2 sequence variants (e.g., residue 627, residue 9) for host adaptation and pathogenicityPB2 presence for diagnosis of influenza A

Beyond the preview

Go deeper on Polymerase basic protein 2 subunit of influenza A virus (PB2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polymerase basic protein 2 subunit of influenza A virus (PB2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call